ARCG.LSE ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP

ETF Healthcare Equity ARK Investment Management LLC London Exchange
- GBX
No recent price
Total assets
8.76M
Expense ratio
0.75%
Dividend yield
-
1-year return
+61.83%
Holdings
33
Since
2024

Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.

What does ARCG.LSE invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (90.0%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (90.0%)
  • Top 3 holdings: 22.8% of the fund

Asset allocation

  • US stocks 90.0%
  • Non-US stocks 7.6%

Top holdings

  • Tempus AI, Inc. Class A Common Stock 8.87%
  • Twist Bioscience Corp 7.55%
  • 10X Genomics Inc 6.41%
  • Natera Inc 5.33%
  • Absci Corp 5.22%
All holdings, sectors and regions

ARK Genomic Revolution UCITS ETF Class A USD Accumulation GBP performance

Sharpe ratio 0.00
This year
+69.17%
1 year
+61.83%
3 years
0.00%
5 years
0.00%

Volatility 41.8% over 1 year. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

ARCG.LSE price

Prices on the chart can differ slightly from the closing prices StockSummer shows.